Cypress Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35
Closed -$2.41K 274
2024
Q2
$2.41K Buy
+35
New +$2.37K ﹤0.01% 278
2021
Q3
Sell
-35
Closed -$2K 211
2021
Q2
$2K Hold
35
﹤0.01% 69
2021
Q1
$2K Hold
35
﹤0.01% 91
2020
Q4
$1K Buy
+35
New +$1.24K ﹤0.01% 96

Other funds holding PBH

Cypress Capital's PBH Position: Q3 2024 in Review

Cypress Capital sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 35 shares — an estimated $2.41K sold.

Cypress Capital first reported a position in PBH in Q4 2020 and held it in 4 quarters. The position peaked at $2.41K in Q2 2024. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Cypress Capital reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital sold 35 Prestige Consumer Healthcare shares in Q3 2024, an estimated $2.41K.
  • Cypress Capital first reported a position in Prestige Consumer Healthcare in Q4 2020 and held it in 4 quarters.
  • Cypress Capital's Prestige Consumer Healthcare position peaked at $2.41K in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.